EA201070806A1 - Состав медленного высвобождения на основе ассоциации гликогена и альгината - Google Patents

Состав медленного высвобождения на основе ассоциации гликогена и альгината

Info

Publication number
EA201070806A1
EA201070806A1 EA201070806A EA201070806A EA201070806A1 EA 201070806 A1 EA201070806 A1 EA 201070806A1 EA 201070806 A EA201070806 A EA 201070806A EA 201070806 A EA201070806 A EA 201070806A EA 201070806 A1 EA201070806 A1 EA 201070806A1
Authority
EA
Eurasian Patent Office
Prior art keywords
glycogen
alginate
association
slow
finging
Prior art date
Application number
EA201070806A
Other languages
English (en)
Other versions
EA018975B1 (ru
Inventor
Винченцо Руссо
Элиза Либерати
Никола Каццолла
Леонардо Маркитто
Лорелла Раньи
Original Assignee
Ацьенде Кимике Рьюните Анджелини Франческо A.K.P.A.Ф. С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ацьенде Кимике Рьюните Анджелини Франческо A.K.P.A.Ф. С.П.А. filed Critical Ацьенде Кимике Рьюните Анджелини Франческо A.K.P.A.Ф. С.П.А.
Publication of EA201070806A1 publication Critical patent/EA201070806A1/ru
Publication of EA018975B1 publication Critical patent/EA018975B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Abstract

Настоящее изобретение относится к фармацевтическому составу контролируемого высвобождения, содержащему по меньшей мере один активный ингредиент, диспергированный в матрице, включающей по меньшей мере один эксципиент медленного высвобождения, содержащий ассоциацию по меньшей мере одного гликогена и по меньшей мере одного альгината с солями щелочно-земельных металлов, и к способу его приготовления. Изобретение также относится к эксципиенту медленного высвобождения, содержащему ассоциацию по меньшей мере одного гликогена и по меньшей мере одного альгината с солями щелочно-земельных металлов, и к способу его получения, и его применению для приготовления фармацевтических составов медленного высвобождения.
EA201070806A 2007-12-28 2008-12-23 Состав медленного высвобождения на основе ассоциации гликогена и альгината EA018975B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07425828 2007-12-28
PCT/EP2008/068256 WO2009083561A1 (en) 2007-12-28 2008-12-23 A slow-release formulation based on an association of glycogen and alginate

Publications (2)

Publication Number Publication Date
EA201070806A1 true EA201070806A1 (ru) 2010-12-30
EA018975B1 EA018975B1 (ru) 2013-12-30

Family

ID=39522216

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070806A EA018975B1 (ru) 2007-12-28 2008-12-23 Состав медленного высвобождения на основе ассоциации гликогена и альгината

Country Status (21)

Country Link
US (1) US8840923B2 (ru)
EP (1) EP2234607B1 (ru)
JP (1) JP5416716B2 (ru)
KR (1) KR101561571B1 (ru)
CN (1) CN101909608B (ru)
AR (1) AR069960A1 (ru)
AT (1) ATE518530T1 (ru)
AU (1) AU2008342571B2 (ru)
BR (1) BRPI0821454B8 (ru)
CA (1) CA2708400C (ru)
DK (1) DK2234607T3 (ru)
EA (1) EA018975B1 (ru)
ES (1) ES2369868T3 (ru)
GE (1) GEP20125636B (ru)
HK (1) HK1145284A1 (ru)
IL (1) IL206124A (ru)
PL (1) PL2234607T3 (ru)
PT (1) PT2234607E (ru)
SI (1) SI2234607T1 (ru)
UA (1) UA98684C2 (ru)
WO (1) WO2009083561A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011007817A (es) 2009-01-23 2011-09-21 A F S P A Aziende Chimichi Riunite Angelini Francesco A C R Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion.
PT2461701E (pt) * 2009-08-03 2016-06-06 Acraf Formulação alimentar compreendendo glicogénio
EP2988725A4 (en) * 2013-04-26 2016-03-09 Mirexus Biotechnologies Inc MONOPERATED GLYCOGEN AND PHYTOGLYCOGEN NANOTEHICLES AND USE THEREOF AS ADDITIVES IN COSMETIC PREPARATIONS, MEDICAMENTS AND FOOD PRODUCTS
CN106137977B (zh) * 2015-04-28 2019-12-13 浙江普利药业有限公司 海参多糖肠溶微丸及其制备方法
US11865099B2 (en) 2015-07-17 2024-01-09 Laboratori Baldacci S.P.A. Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof
ITUB20152290A1 (it) 2015-07-17 2017-01-17 Laboratori Baldacci Spa Prodotto a base di ferro bisglicinato chelato e acido alginico e/o suoi sali idrosolubili, sue formulazioni ed suoi usi farmaceutici
US20190038542A1 (en) * 2016-02-08 2019-02-07 Mirexus Biotechnologies Inc. Moisturizing personal care compositions comprising monodisperse phytoglycogen nanoparticles and a further polysaccharide

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640741A (en) * 1970-02-24 1972-02-08 Hollister Inc Composition containing gel
DE2062715C3 (de) * 1970-12-19 1974-03-21 Efeka Friedrich & Kaufmann Arzneimittelfabrik, 3000 Hannover Verfahren zur Herstellung von oral applizierbaren Arzneimittelzubereitungen mit protrahierter Wirkstoffabgabe und Arzneimittelzubereitung
ATE66143T1 (de) * 1985-01-11 1991-08-15 Abbott Lab Feste zubereitung mit langsamer freisetzung.
JPS62178505A (ja) 1986-02-03 1987-08-05 Maruzen Kasei Kk 化粧料
JPS63290809A (ja) 1987-05-25 1988-11-28 Noebia:Kk 口唇用化粧料
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
IT1255488B (it) 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5807575A (en) 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
IT1298758B1 (it) 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
WO2002041876A1 (en) 2000-11-22 2002-05-30 Lupin Limited Pharmaceutical composition for controlled release of an active ingredient
EP1620076A4 (en) * 2003-04-25 2010-08-25 Kos Life Sciences Inc HIGH SUPERPOREOUS HYDROGEL FORMATION
US20060067917A1 (en) * 2004-09-20 2006-03-30 Athanassios Sambanis Insulin delivery system
US20070099820A1 (en) * 2005-10-19 2007-05-03 Smartcells, Inc. Polymer-drug conjugates

Also Published As

Publication number Publication date
GEP20125636B (en) 2012-09-10
CN101909608B (zh) 2013-01-23
AU2008342571A1 (en) 2009-07-09
JP2011519820A (ja) 2011-07-14
ES2369868T3 (es) 2011-12-07
AR069960A1 (es) 2010-03-03
EP2234607A1 (en) 2010-10-06
WO2009083561A1 (en) 2009-07-09
JP5416716B2 (ja) 2014-02-12
IL206124A0 (en) 2010-11-30
CN101909608A (zh) 2010-12-08
BRPI0821454A2 (pt) 2015-06-16
UA98684C2 (ru) 2012-06-11
EA018975B1 (ru) 2013-12-30
KR20100099728A (ko) 2010-09-13
AU2008342571B2 (en) 2014-03-13
PT2234607E (pt) 2011-09-30
PL2234607T3 (pl) 2011-12-30
DK2234607T3 (da) 2011-11-21
SI2234607T1 (sl) 2011-11-30
BRPI0821454B8 (pt) 2021-05-25
IL206124A (en) 2013-01-31
US20100255083A1 (en) 2010-10-07
BRPI0821454B1 (pt) 2020-01-28
ATE518530T1 (de) 2011-08-15
CA2708400A1 (en) 2009-07-09
EP2234607B1 (en) 2011-08-03
CA2708400C (en) 2016-02-02
US8840923B2 (en) 2014-09-23
HK1145284A1 (en) 2011-04-15
KR101561571B1 (ko) 2015-10-19

Similar Documents

Publication Publication Date Title
EA201070806A1 (ru) Состав медленного высвобождения на основе ассоциации гликогена и альгината
AR054581A1 (es) Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion
CL2015001959A1 (es) (divisional solicitud 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos
UA106878C2 (ru) Фармацевтическая композиция, содержащая 4-[ 3- (4-циклопропан карбонил пиперазин-1-карбонил)-4-фторбензил]-2н-фталазин-1-он или его соль, или сольват, в твердой дисперсии с матричным полимером коповидоном
NZ594022A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
ECSP088239A (es) Composición de liberación de fármaco sostenida
BR112014005134A2 (pt) composição farmacêutica de dissolução rápida
NO20083104L (no) Fast preparat
ECSP088903A (es) Composiciones farmacéuticas de anticuerpo antagonista anti-cd40
AR047928A1 (es) Derivados de tetrahidropiridoindol
IN2015DN02729A (ru)
EA201071218A1 (ru) Улучшенные композиции для активных фармацевтических компонентов с плохой проницаемостью
ES2526606T3 (es) Composición farmacéutica sólida que comprende amlodipina y losartán
BRPI0516019A (pt) composições para o uso contra um ou mais agentes patogênicos
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
BRPI0908124A2 (pt) Composto, ativador de glucoquinase, composição farmacêutica, uso de um composto ou sal farmacologicamente aceitavél do mesmo, e, métodos de ativação da glucoquinase, e para tratar e/ou prevenir uma doença
MX2010005516A (es) Composiciones que comprenden al menos un derivado del acido naftoico, de peroxido de benzoilo y al menos un agente filmogeno.
UA103025C2 (ru) Твердая композиция лекарственного средства замедленного высвобождения
WO2012073170A3 (fr) Composition galénique adaptée à l'administration à un animal non-humain, utilisations de celle-ci et méthodes associées
DK1954251T3 (da) Sammensætning med langvarig frigivelse, som har jernsalt som aktiv bestanddel, fremgangsmåde til fremstilling deraf og anvendelse deraf
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
MX2011010547A (es) Composiciones farmaceuticas estables de diclofenaco.
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU